Inactive Instrument

Eargo, Inc.

Equities

EAR

US2700872086

Advanced Medical Equipment & Technology

Eargo, Inc. Withdraws Financial Guidance for the Fiscal Year Ending December 31, 2021

September 22, 2021 at 04:11 pm EDT

On September 21, 2021, Eargo, Inc. was informed that it is the target of a criminal investigation by the U.S. Department of Justice (the DOJ") related to insurance reimbursement claims the Company has submitted on behalf of its customers covered by federal employee health plans. The Company is cooperating with the investigation. In light of this information, the Company is withdrawing its financial guidance for the fiscal year ending December 31, 2021.

Latest news about Eargo, Inc.

Eargo, Inc.(NasdaqGS:EAR) dropped from S&P TMI Index	Feb. 20	CI
Eargo, Inc.(NasdaqGS:EAR) dropped from NASDAQ Composite Index	Feb. 18	CI
Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings	Jan. 31	CI
Twist Bioscience Names Adam Laponis Chief Financial Officer	Jan. 05	MT
Eargo, Inc. Announces Chief Financial Officer Changes, Effective from January 5, 2024	Dec. 22	CI
Eargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Top Midday Gainers	23-10-30	MT
Wall Street Set to Open Higher Monday as Investors Parse Earnings, Await Fed Meeting	23-10-30	MT
Patient Square Capital, LP entered into an agreement to acquire remaining 23.8% stake in Eargo, Inc. for $13 million.	23-10-29	CI
Eargo Expands Relationship with Best Buy, Growing In-Store Presence to over 500 Locations	23-10-26	CI
Eargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Earnings Flash (EAR) EARGO Reports Q2 Revenue $8.1M	23-08-10	MT
Eargo, Inc. Announces Chief Executive Officer Changes	23-06-27	CI
Eargo, Inc. Announces Resignation of Christian Gormsen as President and Director	23-06-27	CI
Eargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Transcript : Eargo, Inc., Q1 2023 Earnings Call, May 11, 2023	23-05-11
Earnings Flash (EAR) EARGO Reports Q1 Revenue $11.8M, vs. Street Est of $7.6M	23-05-11	MT
North American Morning Briefing : Stock Futures Lower as Bank Worries Persist	23-03-24	DJ
Transcript : Eargo, Inc., Q4 2022 Earnings Call, Mar 23, 2023	23-03-23
Earnings Flash (EAR) EARGO Reports Q4 Revenue $12.9M, vs. Street Est of $8.1M	23-03-23	MT
Eargo, Inc. Auditor Raises 'Going Concern' Doubt	23-03-22	CI
Eargo Regains Compliance With Nasdaq's Minimum Bid Price Requirement	23-02-07	MT
Eargo to Effect 1-for-20 Reverse Stock Split	23-01-11	MT
Hearing Wellness Pioneer Eargo Launches Eargo 7, Its Most Revolutionary Device Yet, at CES	23-01-04	CI
Eargo Says NationsBenefits Plan Members Can Buy Eargo OTC Hearing Aids; Shares Soar After-Hours	22-12-12	MT

Chart Eargo, Inc.

Duration

Period

More charts

Company Profile

Eargo, Inc. is a medical device company. The Company is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. It is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The Company markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user's hearing needs, without pre-programming or a hearing test from a hearing care professional.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+7.84%	218B
DANAHER CORPORATION	+7.35%	183B
INTUITIVE SURGICAL, INC.	+13.04%	134B
BOSTON SCIENTIFIC CORPORATION	+26.03%	106B
SIEMENS HEALTHINEERS AG	-1.33%	61.12B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.89B
AGILENT TECHNOLOGIES, INC.	+0.30%	40.3B
GE HEALTHCARE TECHNOLOGIES INC.	+2.78%	35.53B
RESMED, INC.	+26.14%	32.05B

Other Advanced Medical Equipment & Technology